A LITTLE ABOUT US
Penzymes LLC is an early stage company developing Selective
Intracrine Modulators (SIMs) to block the local formation of steroid hormones in
hormone dependent maligancies of the prostate, breast and endometrium. Lead products in development may benefit
patients with castration resistant
prostate cancer (CRPC), an area of huge unmet clinical need.
Penzymes, LLC was spun out of the University of Pennsylvania through the UPstart company incubator. The Company is located in Philadelphia, PA. |